[Home]   [Full version]  

Pond scum could be key to new cancer therapies

Jul 22 ,Medicine & Health


Researchers at the University of Illinois at Chicago College of Pharmacy are collaborating with the Ohio State University and two other organizations to discover new cancer therapies derived from natural sources such as pond scum and plants from tropical rainforests.

UIC will receive nearly $3 million of the $8 million federal grant to complete multiple projects over five years. Along with Ohio State and UIC, Research Triangle Institute in North Carolina and Bristol-Myers Squibb will assist in the projects. The grant is funded by the National Cancer Institute.

Cyanobacteria, also referred to as blue-green algae or pond scum, is found in nearly every habitat, from oceans to fresh water to bare rocks to soil, and is a source of many unique chemical structures. UIC researchers, led by principal investigator Jimmy Orjala, assistant professor of pharmacognosy, will collect small samples of pond scum throughout the Midwest and grow them in liquid solutions in a temperature-controlled laboratory.

Using methodology he developed to speed up drug discovery from blue-green algae, Orjala will be able to identify pure active compounds at submilligram levels.

"Our goal is to discover naturally occurring anticancer lead compounds that will be more effective than currently available cancer chemotherapeutic agents," Orjala said. If any appear promising, the researchers will grow larger amounts for further evaluation.

Steve Swanson, associate professor and assistant head for research in medicinal chemistry and pharmacognosy, leads the team of UIC researchers that will analyze the biological materials for biological activity once they have been extracted from the algae.

The team will employ assays involving key cellular targets such as the proteasome, which is responsible for breaking down proteins in the cell, Swanson said.

"Cancer cells are known to be particularly sensitive to proteasome inhibitors. Another assay is designed to discover agents that inhibit the enzyme histone deacetylase, which plays a key role in gene expression and is often dysregulated in cancer cells," he said.

Should new compounds be discovered that act on these targets, more detailed studies will be conducted to determine exactly how the substance behaves in cells and in animals, Swanson said.

In addition to the cyanobacteria, plant materials from tropical countries collected by Doel Soejarto, professor of pharmacognosy, will also be analyzed. Information found on UIC's NAPRALERT database, which catalogs biological activities of many plant species found throughout the world, will be used in the project.

Source: University of Illinois at Chicago

Related stories:

Researchers figure out what makes a simple biological clock tick
An interdisciplinary team of researchers at Vanderbilt University has analyzed the simplest known biological clock and figured out what makes it tick. The results of their analysis are published in the March 27 issue of the journal Public Library of Science Biology.
Study solves mystery of mammalian ears
A 30-year scientific debate over how specialized cells in the inner ear amplify sound in mammals appears to have been settled more in favor of bouncing cell bodies rather than vibrating, hair-like cilia, according to investigators at St. Jude Children’s Research Hospital.
Human cells filmed instantly messaging for first time
Cells tugged in one direction sent biochemical signals in the opposite direction in the form of a signature pattern of fluorescent light

Researchers at UCSD and UC Irvine have captured on video for the first time chemical signals that traverse human cells in response to tiny mechanical jabs, like waves spreading from pebbles tossed into a pond. The scientists released the videos and technical details that explain how the visualization effect was created as part of a paper published in the April 21 issue of Nature.
Method removes MTBE from water
A researcher has discovered an effective way to remove a troubling new pollutant from our nation's water sources.
Pratim Biswas, The Stifel and Quinette Jens Professor of Environmental Engineering Science and director of the Environmental Engineering Science Program at Washington University in St. Louis, has found a method for removing the toxin MTBE from water. MTBE (methyl tertiary butyl ether) has been detected at low levels in municipal water sources around the nation and in several cases has made its way into citizens' tap water.
Biswas discovered that a nanostructured form of a compound called titanium dioxide causes MTBE to react with dissolved oxygen so that it yields the harmless gas carbon dioxide.
End-of-life discussions with physicians may have benefits for patients and caregivers
Terminally ill patients who had end-of-life discussions with physicians were not more likely to experience emotional distress, received less aggressive medical care in their final week of life and had a better quality of life near death, compared to patients who did not have these discussions, according to a study in the October 8 issue of JAMA.
Older renal cancer patients appear to benefit from sorafenib treatment
Older and younger patients with renal cancer derive similar benefit from sorafenib therapy and tolerate the drug equally well, according to a study published online October 7 in the Journal of the National Cancer Institute.
Largest review of its kind associates anti-inflammatory drugs with reduced breast cancer risk
Analysis of data from 38 studies that enrolled more than 2.7 million women – the largest of its kind – by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute, and the University of Santiago de Compostela reveals that regular use of Non Steroidal Anti-Inflammatory Drugs (NSAIDs) is associated with a 12 per cent relative risk reduction in breast cancer compared to non-users.
Overweight men face higher risk of dying of prostate cancer
(PhysOrg.com) -- Prostate cancer patients who are overweight and have elevated insulin levels are much more likely to die of the cancer than other patients, say researchers at Harvard University and McGill University. Their research is published in the October issue of The Lancet Oncology.

News discussion:

Medicine & Health news

[Home]   [Full version]